Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Implementing essential diagnostics-learning from essential medicines: A scoping review

View ORCID ProfileMoriasi Nyanchoka, View ORCID ProfileMercy Mulaku, View ORCID ProfileBruce Nyagol, View ORCID ProfileEddy Johnson Owino, View ORCID ProfileSimon Kariuki, View ORCID ProfileEleanor Ochodo
doi: https://doi.org/10.1101/2022.07.04.22277153
Moriasi Nyanchoka
1Centre for Global Health Research, Kenya Medical Research Institute, Kenya
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Moriasi Nyanchoka
  • For correspondence: moriasi.nyanchoka{at}outlook.com
Mercy Mulaku
1Centre for Global Health Research, Kenya Medical Research Institute, Kenya
2Centre for Evidence-based Health Care, Division of Epidemiology and Biostatistics, Faculty of Medicine and Health Sciences, Stellenbosch University, South Africa
3Department of Pharmacy, Faculty of Health Sciences, University of Nairobi, Kenya
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Mercy Mulaku
Bruce Nyagol
1Centre for Global Health Research, Kenya Medical Research Institute, Kenya
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Bruce Nyagol
Eddy Johnson Owino
1Centre for Global Health Research, Kenya Medical Research Institute, Kenya
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Eddy Johnson Owino
Simon Kariuki
1Centre for Global Health Research, Kenya Medical Research Institute, Kenya
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Simon Kariuki
Eleanor Ochodo
1Centre for Global Health Research, Kenya Medical Research Institute, Kenya
2Centre for Evidence-based Health Care, Division of Epidemiology and Biostatistics, Faculty of Medicine and Health Sciences, Stellenbosch University, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Eleanor Ochodo
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Background The World Health Organization (WHO) model list of Essential In vitro Diagnostic (EDL) introduced in 2018 complements the established Essential Medicines List (EML) and improves its impact on advancing universal health coverage and better health outcomes. We conducted a scoping review of the literature on the implementation of the WHO essential lists in Africa to inform the implementation of the recently introduced EDL.

Methods We searched eight electronic databases for studies reporting on the implementation of the WHO EDL and EML in Africa. Two authors independently conducted study selection and data extraction, with disagreements resolved through discussion. We used the Supporting the Use of Research Evidence (SURE) framework to extract themes and synthesized findings using thematic content analysis. We used the Mixed Method Appraisal Tool (MMAT) version 2018 to assess the quality of included studies where applicable.

Results We included 172 studies reporting on EDL and EML after screening 3,813 articles titles and abstracts and 1,545 full-text papers. Most (75%, n=129) included studies were purely quantitative in design comprising descriptive cross-sectional designs (60%, n=104), 15% (n=26) were purely qualitative, and 10% (n=17) had mixed-methods approaches. There were no qualitative or randomised experimental studies about the EDL. The main barrier facing the EML and EDL was poorly equipped health facilities - including unavailability or stock-outs of essential in vitro diagnostics and medicines and inadequate infrastructure to enable health service delivery. Financial and non-financial incentives to health facilities and workers were a key enabler to the implementation of the EML however, their impact differed from one context to another. Fifty-six (33%) of the included studies were of high quality.

Conclusions The EDL implementation at the national level can learn from health system interventions to improve the availability and supply of essential medicines such as financial and non-financial incentives in different contexts.

Plain language summary The World Health Organization (WHO) periodically publishes the Model lists of essential medicines (EML) and essential in vitro diagnostics (EDL) to offer guidance to member states. The model lists help countries prioritise the critical health products that should be widely available and affordable throughout health systems. Countries frequently use these model lists to help develop their local lists of essential medicines and diagnostics. The model list of essential diagnostics was introduced in 2018, while the essential medicines were introduced 45 years ago. This work evaluates current evidence on the implementation of the more established model list of essential medicines to inform the development and implementation of the national list of essential in vitro diagnostics in Africa.

We reviewed results from all available studies that looked at the provision of treatment and/or diagnostic services in Africa and assessed the barriers and enablers for their implementation.

We found 172 articles assessing the provision of treatment and diagnostics in Africa. We looked in detail at the barriers and enablers to implementing the model lists of essential medicines and essential in vitro diagnostics. We also assessed the quality of the included research studies. We combined the results of the studies and established that the health system barriers were the most dominant constraints to implementing the model lists.

Our review found the implementation of the established EML, the new EDL was mainly due to poorly equipped health facilities, including limited availability, and stock outs of essential medicines and tests. It is important to consider these constraints when developing and implementing the EDL at various national levels. EDL Implementation at the national level can learn from interventions to improve the availability and supply of essential medicines. Financial and non-financial incentives may be enabling interventions, but their effect varies in different countries and contexts.

Competing Interest Statement

The authors have declared no competing interest.

Clinical Protocols

https://osf.io/cxwmu/

Funding Statement

This study was funded by UK National Institute for Health Research (NIHR) Global HPSR developmental award (130222). NIHR has no role in the design, conduct, and interpretation of this review.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • Declaration of interests: None declared

  • We have revised the manuscript to remove line numbers to improve readability and remove errors in the document due to use of hyperlinks in some part of the manuscript.

Data Availability

All data in this scoping review is included in the tables, figures and appendices.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Back to top
PreviousNext
Posted July 08, 2022.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Implementing essential diagnostics-learning from essential medicines: A scoping review
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Implementing essential diagnostics-learning from essential medicines: A scoping review
Moriasi Nyanchoka, Mercy Mulaku, Bruce Nyagol, Eddy Johnson Owino, Simon Kariuki, Eleanor Ochodo
medRxiv 2022.07.04.22277153; doi: https://doi.org/10.1101/2022.07.04.22277153
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Implementing essential diagnostics-learning from essential medicines: A scoping review
Moriasi Nyanchoka, Mercy Mulaku, Bruce Nyagol, Eddy Johnson Owino, Simon Kariuki, Eleanor Ochodo
medRxiv 2022.07.04.22277153; doi: https://doi.org/10.1101/2022.07.04.22277153

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Health Systems and Quality Improvement
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)